Insomnia does not appear in the adverse reactions section of the Mounjaro label, and no trial has tested whether tirzepatide causes it. When your sleep problems started is more informative than the drug name — the first week after a dose increase, a month in, or months into a stable dose each point somewhere different.
Because something changed, and it is usually findable. Ask what changed in the week your sleep did, rather than whether the drug can cause insomnia in general.
Dose escalation is the most common answer, because that is when nausea and reflux are most likely, and both are worse lying down. Meal timing is the second, and it shifts on this drug without anyone deciding to shift it. And there is a genuine class-level pattern to compare yourself against: in an analysis of FAERS reports, the median time to onset of GLP-1-related psychiatric adverse events was 31 days, with an interquartile range of 7 to 145 days. So "it started about a month in" is a recognisable shape; "it started the night of my first injection" is not one the data describes.
There is no honest number, because the effect itself has not been established well enough to have a duration. Anyone quoting you one is inventing it.
What is documented is that the common adverse reactions on this drug — the gastrointestinal ones — often ease between dose escalations as the body adjusts. So if your sleep is being disturbed through one of those indirect routes, it plausibly follows the same curve. If it does not, and the nights are still bad on a stable dose weeks later, that pattern is telling you something you can act on.
Match your own timing against the column below before deciding what this is. It is the fastest way to tell an adjustable side effect from something that needs its own treatment.
Mounjaro is indicated for glycemic control in type 2 diabetes, which puts its readers in a group that a weight-management drug's readers are not: people who may also be taking insulin or an insulin secretagogue. The label carries a specific warning about that combination — concomitant use may increase the risk of hypoglycemia, including severe hypoglycemia, and reducing the dose of the secretagogue or insulin may be necessary.
A night-time low can wake you, and it does not feel like insomnia from the inside. Sweating, shakiness, a racing heart, waking suddenly and hungry, or a headache in the morning are the things to mention. This is worth raising promptly with whoever manages your diabetes rather than filed under sleep problems, and it is the one item on this page that is genuinely urgent.
Very little, and the parts of "very little" are worth telling apart. Insomnia is absent from the adverse reactions section of the Mounjaro label — meaning it was not a finding in the trials submitted for approval. The class-level FAERS signal above is a reporting odds ratio from voluntary, unverified reports, which is a prompt for research rather than a cause. And that analysis runs through early 2023, while tirzepatide is a dual GIP/GLP-1 agonist that only reached the market in 2022, so it barely appears in the dataset at all.
One more thing worth correcting, because it circulates widely: the specific insomnia figure people quote about this drug class — a reporting odds ratio of 2.93 — was found for dulaglutide, a different drug. It is not a tirzepatide finding.
Work the timing column first, because those routes are adjustable and a dose or meal change is a conversation your prescriber can have this week. Then do the ordinary things properly: a fixed wake time every day, a cool room, and a caffeine cutoff set by your own clearance.
If the nights have run three or more times a week for three months with consequences during the day, that meets the clinical definition of chronic insomnia regardless of what set it off. The American College of Physicians recommends CBT-I as the initial treatment for every adult with it, ahead of medication — and it runs on a separate track from your diabetes care.
Mounjaro is a weekly tirzepatide injection that’s FDA-approved for those with type 2 diabetes. Although it’s designed to help type 2 diabetics manage their blood glucose, it can also be prescribed off-label for weight loss and weight management for those with obesity.
Clinical trials didn’t find tiredness as a side effect, but users are reporting otherwise.
Below, we’ve covered why Mounjaro can make you feel tired and how you can use the RISE app to get more energy.
Heads-up: Mounjaro is a relatively new drug, so there’s a lot we don’t know about its side effects. Scientific research is lagging behind the increase in users.
“In the clinical trials we have so far, tiredness isn’t reported as a side effect of Mounjaro. However, some users report feeling tired on Mounjaro, and the drug can cause side effects, like vomiting and diarrhea, which can make it hard to get enough sleep," says Dr. Chester Wu, who is double board certified in Psychiatry and Sleep Medicine, and provides sleep medicine services, medication management, and psychotherapy to adults at his private sleep medicine and psychiatry practice.
Mounjaro may make you feel tired. Tiredness isn’t listed as a side effect of Mounjaro, but users have reported it online. And Mounjaro can cause side effects — like GI issues — which can disrupt your sleep.
The Food and Drug Administration (FDA) doesn’t list tiredness as a side effect of Mounjaro, but that conclusion comes from a handful of clinical trials.
The FDA states clinical trials are conducted under “widely varying conditions” and rates of side effects “may not reflect the rates observed in practice.” In non-trial conditions, there are many factors that could impact side effects, including health conditions and medications.
Plus, these trials included people with type 2 diabetes, so it’s unclear whether Mounjaro could cause fatigue in those without the health condition.
And to be listed as a common side effect, it has to occur in 5% or more of users. It’s unclear whether fatigue happens in a smaller percentage of users. This may sound small, but as use of the drug increases, this can end up affecting a lot of people.
Fatigue is listed as a side effect of Zepbound, which contains the same active ingredient (tirzepatide) in the same doses as Mounjaro.
Beyond scientific research, there are anecdotal reports of Mounjaro causing tiredness.
Some users report feeling tired when taking a 5-mg dose of Mounjaro, but not the starting 2.5-mg dose. Others report fatigue on the day they take Mounjaro and for the next two days, feeling tired after eating, or getting tired more quickly after exercise.
Research from 2023 published in Brain Sciences analyzed Reddit, YouTube, and TikTok posts about the side effects of semaglutide and tirzepatide type 2 diabetes and weight loss drugs, including Ozempic, Wegovy, Rybelsus, and Mounjaro.
Users mentioned sleep-related issues the most, such as insomnia, anxiety, depression, and general mental health issues. Some said tirzepatide triggered insomnia.
Heads-up: Tiredness and sleepiness aren’t the same thing. Tiredness is when you feel fatigued, but you might not be able to fall asleep. Sleepiness is when you could fall asleep if you tried. Mounjaro may cause tiredness and sleepiness (more on why soon).
Because this gets confusing: Tirzepetide — the active ingredient in the drugs Mounjaro and Zepbound — is a dual-acting glucagon-like peptide-1 receptor agonist (GLP-1 receptor agonist) and a glucose-dependent insulinotropic polypeptide (GIP) receptor agonist, or GLP-1/GIP receptor agonist. Semaglutide — the active ingredient in Ozempic, Wegovy, and Rybelsus — is only a GLP-1 receptor agonist.
As a dual-acting receptor agonist, Mounjaro can be a more effective treatment for type 2 diabetes and obesity, as it targets multiple pathways involved in glucose regulation and weight management, compared to single-acting receptor agonists like Ozempic. But this may mean it comes with more fatigue. More research is needed into all of these weight loss and diabetes medications.
We’ve covered more on GLP-1 receptor agonists:
And GLP1/GIP receptor agonists:
RISE makes it easy to improve your sleep and daily energy to reach your potential
It’s unclear why Mounjaro makes you tired. It may be due to eating fewer calories, low blood sugar, changes in dopamine levels or exercise, or side effects like GI issues and anxiety disrupting your sleep.
Here’s more on how Mounjaro can make you tired:
You may also feel tired due to the common culprits of high sleep debt and circadian misalignment, which can tank your energy whether you’re on Mounjaro or not. We cover how to fix those soon.
Mounjaro can affect sleep by causing side effects like vomiting, diarrhea, anxiety, and depression. You may also change your diet and exercise habits on Mounjaro, which can impact sleep. For example, hunger pangs from cutting calories can keep you up at night, and exercising less can make it harder to drift off.
Mounjaro may cause insomnia. A 2023 study into social media reports of GLP-1 receptor agonist side effects found some users reported their insomnia got better, while others said it got worse. There were reports of tirzepatide triggering insomnia in some.
Mounjaro may cause sleep problems that look a lot like insomnia. But it’s not clear whether these sleep problems can be classified as clinical insomnia.
The International Classification of Sleep Disorders (ICSD-3) defines insomnia as having:
Having these sleep problems at least three nights a week for at least three months could be a sign of insomnia. Having them for one to three months could be a sign of episodic insomnia.
Seek medical advice if you think you have insomnia. You may need different, or additional, treatments compared to other Mounjaro sleep problems.
Mounjaro may improve your sleep, either straight away or with time. As a diabetes treatment, Mounjaro can help type 2 diabetics manage high blood sugar levels. And as diabetes is linked to sleep disturbances and sleep disorders like sleep apnea, better management of the condition may lead to better sleep.
Mounjaro can also help you lose weight, which may reduce snoring, sleep apnea, and your odds of health conditions like high blood pressure and heart disease — which have been linked to sleep disorders like insomnia.
GLP-1 receptor agonists may improve sleep apnea outside of weight loss. We’ve covered more on whether Ozempic can potentially help sleep apnea here.
Healthy lifestyle changes are usually encouraged on Mounjaro, and these can help you sleep. You may start exercising or eating smaller, healthier meals.
Mounjaro may even reduce your cravings for alcohol and cigarettes, and cutting down on these can also improve your sleep.
Plus, the 2023 research we mentioned earlier found reports of tirzepatide helping some people wake up feeling refreshed and rested. And GLP-1/GIP receptor agonists helped improve insomnia, anxiety, and depression for some.
Learn how sleep helps you lose weight here.
It’s unclear how long Mounjaro fatigue lasts. Fatigue may improve as your body gets used to the drug. You may also start sleeping better as other side effects improve.
You’d usually stay on a dose of Mounjaro for four weeks before moving up to a higher dose. GI issues tend to happen when your dose increases, but it’s unclear whether the same happens with fatigue. Long-term studies are needed.
The common side effects of Mounjaro include:
These side effects were reported by 5% or more of users in clinical trials. It’s not clear whether Mounjaro caused fatigue in a smaller percentage of people.
Serious side effects include allergic reactions, pancreatitis (inflammation of the pancreas), diabetic retinopathy complications, kidney problems, and gallbladder problems like gallbladder disease.
Mounjaro has a boxed warning of an increased risk of thyroid C-cell tumors and a thyroid cancer called medullary thyroid carcinoma (MTC).
You can improve Mounjaro fatigue by paying back sleep debt, getting in sync with your circadian rhythm, improving your sleep hygiene, managing GI issues and anxiety, eating a balanced diet, and getting some exercise.
Here’s how:
The best way to feel less tired is to get the right amount of sleep for you. RISE calculates how much sleep you individually need. Despite what you may hear, it’s not simply eight hours for everyone. When we looked at how much sleep 1.95 million RISE users aged 24 and up needed, we found it ranged from five hours to 11 hours 30 minutes.
While fatigue isn’t listed as a side effect of Mounjaro, some users say the drug makes them feel tired and other side effects can disrupt your sleep.
Use RISE to get better sleep and more energy while on Mounjaro. The app helps you pay back sleep debt, sync up with your circadian rhythm, and perfect your sleep hygiene.
Users say RISE makes a real difference to their days.
“It showed me how my late nights add up to sleep debt, which sabotages my energy. Since I've been using RISE, no more afternoon crashes.” Read the review.
And it doesn’t take long — 80% of users feel more energy within five days
There's no honest number, because the effect hasn't been established well enough to have a duration. The gastrointestinal adverse reactions often ease between dose escalations, so sleep disturbed through those routes plausibly follows the same curve. Nights that are still bad weeks into a stable dose are telling you something different.
Look at what changed in the same week. A dose increase, a shift in when you eat, or reflux that's worse lying flat are the usual answers. The class pattern is a median 31 days to onset for psychiatric adverse events, so "about a month in" is a recognisable shape and "the first night" isn't one the data describes.
It can be, and it's worth ruling out fast. The Mounjaro label warns that taking it alongside insulin or an insulin secretagogue may increase the risk of hypoglycemia, including severe hypoglycemia. Sweating, shakiness, a racing heart, waking suddenly hungry, or a morning headache are what to mention to whoever manages your diabetes.
Start with the adjustable routes — dose timing, meal timing, reflux — because those are a conversation with your prescriber rather than a diagnosis. Then hold a fixed wake time and a caffeine cutoff. If the nights have run three or more times a week for three months, that is chronic insomnia by definition, and a sleep therapist can assess whether CBT-I fits. The clinic treats the insomnia; it does not manage your medication or your diabetes.
